Skip to main content
Log in

Selective apoptotic and genotoxic effects of pomegranate peel extract against human hepatocellular carcinoma HepG2 cell line

  • Research Article
  • Published:
Advances in Traditional Medicine Aims and scope Submit manuscript

Abstract

Finding a therapeutic agent that is selective, non-toxic to normal cells, and does not develop resistance or unpleasant side effects became the most challenging aspect in cancer therapy. Our study investigates the potential antitumorigenic effects of pomegranate peel extract against human hepatocellular carcinoma HepG2 cell line. The effect of the extract on cell viability, DNA fragmentation, cell cycle arrest, and expression of cancer related genes in human hepatocellular carcinoma cell line (HepG2), and normal human hepatocyte cell line (THLE2) was evaluated using MTT, comet assay, flow cytometry and real time PCR, respectively. Unlike THLE2 cells, the pomegranate peel extract significantly decreased cell viability accompanied by DNA fragmentation and cell cycle arrest in HepG2 cells. It also significantly decreased the expression levels of Cyclooxygenase-2, B-cell lymphoma 2, vascular permeability factor, matrix metalloproteinase -9, cyclin B1, and cyclin dependent kinase1 while the expression levels of BCL2-associated X protein, and p21 genes were significantly increased. The obtained results suggest a potential antitumorigenic effect of pomegranate peel extract against HepG2 cell lines.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

Availability of data and materials

Data supporting this study is included within the article.

References

Download references

Funding

No funds, grants, or other support was received.

Author information

Authors and Affiliations

Authors

Contributions

Basal*, W.T.: the corresponding author. He made substantial contributions to the conception, design of the work, and the acquisition, analysis, and interpretation of data. He also revised the manuscript. El-Sonousy, k.N.: Pivotal role in data analysis and interpretation. El-Sakka, M.: substantial contributions in acquisition, analysis, and interpretation of data. Issa, A.M.: Pivotal role in design of the work, data acquisition, analysis and interpretation. She also revised the work.

Corresponding author

Correspondence to Wesam T. Basal.

Ethics declarations

Ethical approval

The experiments were consented by The Institutional Animal Care and Use Committee (IACUC), Faculty of Science, Cairo University with the approval number (CU/I//F/14/23).

Conflict of interest

Wesam T. Basal has no conflict of interest. Medhat El‑Sakka has no conflict of interest. Neima K. El‑Sonousy has no conflict of interest. Aliaa M. Issa has no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Basal, W.T., El-Sakka, M., El-Sonousy, N.K. et al. Selective apoptotic and genotoxic effects of pomegranate peel extract against human hepatocellular carcinoma HepG2 cell line. ADV TRADIT MED (ADTM) (2024). https://doi.org/10.1007/s13596-024-00753-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s13596-024-00753-2

Keywords

Navigation